Close Menu

North America

The test uses prognostic markers to group women based on their risk of 10-year recurrence of ductal carcinoma in situ.

The new service, slated for launch in the second half of 2021, will allow Myriad to expand its cancer tumor profiling services.

The test uses a technology called Switch-Blocker that is co-owned by the companies and enables both viral detection and strain discrimination.

The investment bank said that Lucira's COVID-19 single-use test could have widespread use with potential for adoption in the over-the-counter markets.

Under the deal, expected to close in April, Agilent will pay $550 million in cash on closing and up to an additional $145 million based on future milestones.

The RT-PCR-based test is designed to detect three SARS-CoV-2 genes in saliva samples collected in the presence of a trained observer.

The firm attributed its quarterly and annual revenue gains primarily to sales of COVID-19 testing sample collection devices.

The Seattle-based firm saw collaboration revenues fall 83 percent from Q4 2019 and 73 percent from full-year 2019.

A UCLA-led team uncovered differences in DNA methylation patterns between patients with persistent and resolving methicillin-resistant Staphylococcus aureus infections.

The liquid biopsy method analyzes fragment ends within recurrently protected regions in cell-free DNA from a patient's urine sample.  


In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.